Roche diagnostics corp:1106277 [13-004262]
Ended Awarded Last action
- Contract number
- HHSN30200014
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,272
Award facts
- Contract value 100% obligated
- $19,272.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, received a Blanket Purchase Agreement (BPA) call award valued at $19,272.20 from the National Human Genome Research Institute on May 15, 2013. This firm fixed-price contract, which carries no set-aside designation, represents a call against an existing BPA and demonstrates Roche's continued role as a supplier of diagnostic solutions to federal healthcare agencies. The contract is classified as a child award, indicating it derives from a larger indefinite delivery vehicle, and performance is specified for Castleton, Indiana, with an ultimate completion date of December 31, 2013.
As a leading global provider of diagnostic technologies, Roche Diagnostics supplies federal agencies with advanced laboratory equipment, testing systems, reagents, and clinical testing services. The company maintains multiple significant BPA and Indefinite Delivery Contract vehicles with federal agencies, primarily through General Services Administration Schedule contracts including the Critical Analyzers, Laboratory and In Vitro Diagnostics, Reagents, Test schedules. These pre-negotiated vehicles enable efficient acquisition of Roche's diagnostic technologies across the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare organizations, supporting critical functions ranging from molecular pathology to point-of-care testing and specialized reagent supply.
Quick answers
Who was awarded contract HHSN30200014?
HHSN30200014 was awarded to Roche Diagnostics Corporation by National Human Genome Research Institute (National Institutes of Health) on May 15, 2013.
How much is contract HHSN30200014 worth?
The government has obligated $19,272 on HHSN30200014.
Is contract HHSN30200014 an order under another contract?
Yes. HHSN30200014 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN30200014 competed?
The extent of competition for HHSN30200014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award